Changes in LAR-GECO1 relative to R-GECO1 are shown as green boxes and in LAR-GECO1.2 relative to R-GECO1.2 are shown as pink boxes. Residue numbering is consistent with the crystal structure of GCaMP2 (PDB ID 3EVR) [31] .
Figure S3 Characterization of LAR-GECO1 and LAR-GECO1.2
For (A-D), the Ca 2+ -free state is represented with a dotted line and the Ca 2+ -bound state by a solid line. All spectra were measured as previously described [6] . (A and B) Excitation (Ex) and emission (Em) spectra of LAR-GECO1 (A) and LAR-GECO1.2 (B) in the Ca 2+ -free and Ca 2+ -bound states. (C and D) Absorbance (Abs) and emission (Em) spectra of LAR-GECO1 (C) and LAR-GECO1.2 (D) in the Ca 2+ -free and Ca 2+ -bound states. (E and F) Fluorescence intensities of LAR-GECO1 (E) and LAR-GECO1.2 (F) as a function of pH.
Figure S4 Characterization of ER-LAR-GECO1 in HeLa, HEK-293 and U2-OS cells (A) HeLa cells, (B) HEK-293 cells and (C) a U2-OS cell co-expressing ER-LAR-GECO1 (red)
and Cyto-G-GECO1.1 (green), imaged in the resting state (left panels) and after treatment with histamine (100 µM, right panels). Images after treatment with histamine correspond to the time of maximal increase in the fluorescence intensity of Cyto-G-GECO1. 
Table S1
List of substitutions for new GECOs described in this work. Residues are numbered as described in Figure S2 Protein LAR-GECO1 substitutions relative to R-GECO1 LAR-GECO1.2 substitutions relative to R-GECO1.2
LAR-GECO1
V51W, I113V, N356S, D381Y, F395A, V411A, L415I LAR-GECO1.2 N45I, A47R, E138V, K324E
